%0 Journal Article
%T Synthesis, in vitro antifungal evaluation and in silico study of 3-azolyl-4-chromanone phenylhydrazones
%A Adile Ayati
%A Mehraban Falahati
%A Hamid Irannejad
%A Saeed Emami
%J DARU Journal of Pharmaceutical Sciences
%D 2012
%I BioMed Central
%R 10.1186/2008-2231-20-46
%X The 3-azolyl-4-chromanone phenylhydrazones were synthesized via ring closure of 2-azolyl-2'-hydroxyacetophenones and subsequent reaction with phenylhydrazine. The biological activity of title compounds was evaluated against different pathogenic fungi including Candida albicans, Saccharomyces cerevisiae, Aspergillus niger, and Microsporum gypseum. Docking study, in silico toxicity risks and drug-likeness predictions were used to better define of title compounds as antifungal agents.The in vitro antifungal activity of compounds based on MIC values revealed that all compounds showed good antifungal activity against C. albicans, S. cerevisiae and M. gypseum at concentrations less than 16 ¦Ìg/mL. Among the test compounds, 2-methyl-3-imidazolyl derivative 3b showed the highest values of drug-likeness and drug-score.The 3-azolyl-4-chromanone phenylhydrazones considered as analogs of 3-azolyl-4-chromanone oxime ethers basically designed as antifungal agents. The antifungal activity of title compounds was comparable to that of standard drug fluconazole. The drug-likeness data of synthesized compounds make them promising leads for future development of antifungal agents.Recently, the incidence of life-threatening fungal diseases has dramatically increased due to the rising number of immunocompromised patients, increased use of anti-cancer drugs, and immunosuppressive therapy for organ transplantation [1]. On the other hand, the currently available antifungal drugs suffer from toxicity, greatest potential drug interactions with other drugs, insufficient pharmacokinetics properties, and development of resistance [2]. Consequently, it is urgent to develop new broad-spectrum antifungal agents with optimum pharmacokinetics and less toxicity.Several antifungal drugs, including azoles, polyenes, echinocandins and allylamines have been developed to overcome the fungal infections [3]. However, in comparison to the large number of antibacterial drugs the number of clinically available a
%K Azole antifungals
%K Antifungal activity
%K 1£¿H-imidazole
%K 1
%K 2
%K 4-triazole
%K Chroman-4-one
%K Hydrazone
%U http://www.darujps.com/content/20/1/46